ABBV has been in the news 316% more than usual
Sep 30, 2025, 12:31 PM
0.90%
What does ABBV do
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
ABBV has been in the news recently: AbbVie plans to launch ELAHERE® in the U.K. for treating platinum-resistant ovarian cancer at a price equal to the U.S. market. The company is also constructing a new API facility in North Chicago, expected to be completed by 2027, as part of a $10 billion investment in the U.S.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.